TG Therapeutics Inc (NASDAQ:TGTX)

15.79
Delayed Data
As of Mar 27
 -0.27 / -1.68%
Today’s Change
4.42
Today|||52-Week Range
20.00
-0.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsShort Term Investment Cash9.7M6.7M24.0M--
 
 
 
 
Cash & Short Term Investments9.7M16.5M40.5M--
 
 
 
 
 
ReceivablesReceivables0.000.0027.2K--
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsPrepaid Expenses--2.0M1.7M--
 
 
 
Other Current Assets87.2K29.1K47.8K--
 
 
 
 
Current Assets9.8M18.5M42.3M--
 
 
 
 
 
Total AssetsIntangible Assets4.7M3.6M799.4K--
 
 
 
 
Other Assets4.7M3.6M884.5K--
 
 
 
 
Total Assets14.5M22.1M48.1M86.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable666.6K1.1M4.8M--
 
 
 
 
Short Term Debt877.8K677.8K677.8K--
 
 
 
 
Accrued Expenses0.000.00190.0K--
 
 
Other Current Liabilities61.9K275.9K342.4K--
 
 
 
 
Other Liabilities1.6M2.2M6.3M--
 
 
 
 
 
Total LiabilitiesLong Term Debt3.3M2.5M64.5K--
 
 
 
 
Total Liabilities4.9M6.5M8.1M--
 
 
 
 
 
EquityMinority Interest-36.0K-8.1M0.00--
 
 
 
Preferred Stock413.000.000.00--
 
 
Common Equity9.6M15.6M40.1M80.1M
 
 
 
 
 
Total Shareholder Equity9.6M15.6M40.1M80.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding90.0K25.8M34.3M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account